Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIMP2 Level for Predicting CSA-AKI
NCT06871826Phase 2Completed
- Sponsor
- Wuhan University
- Start
- Jul 2023
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 2 trial (3 arms), sponsored by Wuhan University. Primary endpoint: Development of Cardiac Surgery-Associated Acute Kidney Injury at 1 week. Started Jul 2023; status: completed.
Beyond the preview
Go deeper on NCT06871826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06871826.